<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26848777</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57.</ArticleTitle><Pagination><StartPage>8797</StartPage><EndPage>8808</EndPage><MedlinePgn>8797-808</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.7122</ELocationID><Abstract><AbstractText>There is no effective drug to treat EV71 infection yet. Traditional Chinese herbs are great resources for novel antiviral compounds. Here we showed that Oblongifolin M (OM), an active compound isolated from Garcinia oblongifolia, potently inhibited EV71 infection in a dose dependent manner. To identify its potential effectors in the host cells, we successfully identified 18 proteins from 52 differentially expressed spots by comparative proteomics studies. Further studies showed that knockdown of ERp57 inhibited viral replication through downregulating viral IRES (internal ribosome entry site) activities, whereas ectopic expression of ERp57 increased IRES activity and partly rescued the inhibitory effects of OM on viral replication. We demonstrated that OM is an effective antiviral agent; and that ERp57 is one of its cellular effectors against EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yaqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shenzhen Center for Disease Control and Prevention (Shenzhen CDC), Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xinchun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases, The 3rd Peoples' Hospital of Shenzhen, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Boping</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases, The 3rd Peoples' Hospital of Shenzhen, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Letter and Sciences, University of California at Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Hsiang-Fu</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Canhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yuquan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jian-dong</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ming-Liang</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013729">Terpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1</RegistryNumber><NameOfSubstance UI="D019704">Protein Disulfide-Isomerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1.</RegistryNumber><NameOfSubstance UI="C085868">PDIA3 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015180" MajorTopicYN="N">Electrophoresis, Gel, Two-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029760" MajorTopicYN="N">Garcinia</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019704" MajorTopicYN="N">Protein Disulfide-Isomerases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013729" MajorTopicYN="N">Terpenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ERp57</Keyword><Keyword MajorTopicYN="N">Oblongifolin M</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword></KeywordList><CoiStatement><b>CONFLICTS OF INTEREST</b>. The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26848777</ArticleId><ArticleId IdType="pmc">PMC4891005</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.7122</ArticleId><ArticleId IdType="pii">7122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chang HL, Chio CP, Su HJ, Liao CM, Lin CY, Shau WY, Chi YC, Cheng YT, Chou YL, Li CY, Chen KL, Chen KT. The association between enterovirus 71 infections and meteorological parameters in Taiwan. PLoS One. 2012;7:e46845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3465260</ArticleId><ArticleId IdType="pubmed">23071650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review of enterovirus 71 vaccines. Clin Infect Dis. 2015;60:797&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Yin H, An Z, Feng Z. Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine. 2015;33:1107&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">25444807</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YP, Liang ZL, Xia JL, Wu JY, Wang L, Song LF, Mao QY, Wen SQ, Huang RG, Hu YS, Yao X, Miao X, Wu X, Li RC, Wang JZ, Yin WD. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial. J Infect Dis. 2014;209:46&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">23922377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Ke C, Zhang Y, Liu R, Chen J, Kung HF, He ML. The interaction between human enteroviruses and type I IFN signaling pathway. Crit Rev Microbiol. 2015;41:201&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">23919297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Hsieh FC, Lin YJ, Wu TY, Lin CW, Lin CT, Tang NY, Jinn TR. Magnesium lithospermate B and rosmarinic acid, two compounds present in Salvia miltiorrhiza, have potent antiviral activity against enterovirus 71 infections. Eur J Pharmacol. 2015;755:127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">25773498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji P, Chen C, Hu Y, Zhan Z, Pan W, Li R, Li E, Ge HM, Yang G. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Biol Pharm Bull. 2015;38:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25744451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wang P, Chen X, Wang W, Jin Y. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway. Antiviral Res. 2015;119:47&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">25912818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Sun C, Tao X, Ren Y. Anti-in fl ammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Natural product research. 2012;26:1746&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pubmed">21999396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhu J. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review. Journal of viral hepatitis. 2013;20:445&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">23730837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter D, Schwarz S, Wang K, Zhang R, Sun B, Schwarz W. Genistein as antiviral drug against HIV ion channel. Planta medica. 2014;80:682&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">24963618</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz S, Sauter D, Wang K, Zhang R, Sun B, Karioti A, Bilia AR, Efferth T, Schwarz W. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta medica. 2014;80:177&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7171712</ArticleId><ArticleId IdType="pubmed">24458263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Lin LT, Huang HH, Yang CM, Lin CC. Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro. Antiviral Res. 2008;77:14&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17931713</ArticleId></ArticleIdList></Reference><Reference><Citation>Duangsrisai S, Choowongkomon K, Bessa LJ, Costa PM, Amat N, Kijjoa A. Antibacterial and EGFR-Tyrosine Kinase Inhibitory Activities of Polyhydroxylated Xanthones from Garcinia succifolia. Molecules. 2014;19:19923&#x2013;19934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6271254</ArticleId><ArticleId IdType="pubmed">25460314</ArticleId></ArticleIdList></Reference><Reference><Citation>Samprasit W, Opanasopit P, Sukma M, Kaomong-Kolgit R. Antibacterial activity of Garcinia mangostana extracts on oral pathogens. Minerva stomatologica. 2014;63:249&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">25299359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackeen MM, Ali AM, Lajis NH, Kawazu K, Kikuzaki H, Nakatani N. Antifungal garcinia acid esters from the fruits of Garcinia atroviridis. Zeitschrift fur Naturforschung C, Journal of biosciences. 2002;57:291&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">12064729</ArticleId></ArticleIdList></Reference><Reference><Citation>Suttirak W, Manurakchinakorn S. In vitro antioxidant properties of mangosteen peel extract. Journal of food science and technology. 2014;51:3546&#x2013;3558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252444</ArticleId><ArticleId IdType="pubmed">25477623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu WW, Tan HS, Xu HX. [Research progress of chemistry and anti-cancer activities of natural products from Chinese Garcinia plants] Yao xue xue bao = Acta pharmaceutica Sinica. 2014;49:166&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">24761605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalakrishnan G, Banumathi B, Suresh G. Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives. Journal of natural products. 1997;60:519&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">9213587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Joseph GS, Singh RP. Antioxidant and antiplatlet aggregation properties of bark extracts of Garcinia pedunculata and Garcinia cowa. Journal of food science and technology. 2014;51:1626&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108668</ArticleId><ArticleId IdType="pubmed">25114359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zhang DD, Lao YZ, Fu WW, Liang S, Yuan QH, Yang L, Xu HX. Cytotoxic and anti-inflammatory prenylated benzoylphloroglucinols and xanthones from the twigs of Garcinia esculenta. Journal of natural products. 2014;77:1700&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">24960143</ArticleId></ArticleIdList></Reference><Reference><Citation>Han QB, Qiao CF, Song JZ, Yang NY, Cao XW, Peng Y, Yang DJ, Chen SL, Xu HX. Cytotoxic prenylated phenolic compounds from the twig bark of Garcinia xanthochymus. Chemistry &amp; biodiversity. 2007;4:940&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pubmed">17511007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Wu CF, Hsiao NW, Chang CY, Li SW, Wan L, Lin YJ, Lin WY. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents. 2008;32:355&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="pubmed">18701259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Lai CC, Lai CH, Sue SC, Lin CW, Hung CH, Lin TH, Hsu WY, Huang SM, Hung YL, Tien N, Liu X, Chen CL, Tsai FJ. Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. European journal of medicinal chemistry. 2013;62:206&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23353754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu QC, Wang Y, Liu YP, Zhang RQ, Li X, Su WH, Long F, Luo XD, Peng T. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. European journal of pharmaceutical sciences. 2011;44:392&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Tao L, Fu WW, Liang S, Yang YF, Yuan QH, Yang DJ, Lu AP, Xu HX. Prenylated benzoylphloroglucinols and xanthones from the leaves of Garcinia oblongifolia with antienteroviral activity. Journal of natural products. 2014;77:1037&#x2013;1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">24679044</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K, Helenius A. Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell. 2007;131:516&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981119</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana AY, Guerrero CA, Acosta O. Implication of Hsc70, PDI and integrin alphavbeta3 involvement during entry of the murine rotavirus ECwt into small-intestinal villi of suckling mice. Arch Virol. 2013;158:1323&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">23404461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He YQ, Yi LN, Zan H, Kung HF, He ML. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol. 2011;17:4135&#x2013;4142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol. 2011;37:313&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Mao Q, Gao F, Wang J. Progress on the research and development of human enterovirus 71 (EV71) vaccines. Front Med. 2013;7:111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">23247645</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Xu M, Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res. 2013;97:183&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao Y, Wan G, Liu Z, Wang X, Ruan P, Xu W, Xu D, Xie W, Zhang Y, Xu H, Xu N. The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation. Autophagy. 2014;10:736&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119057</ArticleId><ArticleId IdType="pubmed">24642486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin MC, Wang H, Chan CY, Jiang L, Ngai SM, Yu J, He ML, Shaw PC, Yew DT, Sung JJ, Kung HF. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics. 2007;7:3097&#x2013;3104.</Citation><ArticleIdList><ArticleId IdType="pubmed">17676662</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Jia HL, Liu CW, Xu YF, Mao LJ, He CH, Yin GQ, Lin JH, Tao JP, Zhu L. Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71. BMC Infect Dis. 2013;13:383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765220</ArticleId><ArticleId IdType="pubmed">23961958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson SF, Korsgren S, Ponten F, Korsgren O. Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol. 2013;229:719&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pubmed">23335350</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Zhang XA, Wang H, Wang X, Meng CL, Chan CY, Yew DT, Tsang KS, Li K, Tsai SN, Ngai SM, Han ZC, Lin MC, He ML, Kung HF. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord and placenta: implication in the migration. Adv Exp Med Biol. 2011;720:51&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">21901618</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, Shieh DB, Chen SH, Wang JR, Lai MD, Chang CF. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol. 2015;89:4527&#x2013;4538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RY, Kuo RL, Ma WC, Huang HI, Yu JS, Yen SM, Huang CR, Shih SR. Heat shock protein-90-beta facilitates enterovirus 71 viral particles assembly. Virology. 2013;443:236&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">23711381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Chen Y, Han QB, Chan CY, Wang H, Liu Z, Cheng CH, Yew DT, Lin MC, He ML, Xu HX, Sung JJ, Kung HF. Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics. 2009;9:242&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">19086098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LK, Lin T, Zhu SL, Xianyu LZ, Lu SY. Global quantitative proteomic analysis of human glioma cells profiled host protein expression in response to enterovirus type 71 infection. Proteomics. 2015;15:3784&#x2013;3796.</Citation><ArticleIdList><ArticleId IdType="pubmed">26350028</ArticleId></ArticleIdList></Reference><Reference><Citation>Coe H, Jung J, Groenendyk J, Prins D, Michalak M. ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. J Biol Chem. 2010;285:6725&#x2013;6738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825467</ArticleId><ArticleId IdType="pubmed">20022947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. Journal of virology. 2012;86:3767&#x2013;3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther. 2011;16:51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Zhao FP, Peng Z, Zhang MW, Lin SX, Liang BJ, Zhang B, Liu X, Wang L, Li G, Tian WD, Peng Y, He ML, Li XP. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. Oncotarget. 2014;5:11319&#x2013;11332. doi: 10.18632/oncotarget.2435.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.2435</ArticleId><ArticleId IdType="pmc">PMC4294357</ArticleId><ArticleId IdType="pubmed">25237831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, Li XP. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 2011;71:225&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">21199804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L, Luo H, Peng X, Li G, Tian W, He M, Li X. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer. 2014;110:392&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3899774</ArticleId><ArticleId IdType="pubmed">24327016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Yu J, Chan HL, Chen YC, Wang H, Chen Y, Chan CY, Go MY, Tsai SN, Ngai SM, To KF, Tong JH, He QY, Sung JJ, Kung HF, Cheng CH, et al. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics. 2009;8:2582&#x2013;2594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773723</ArticleId><ArticleId IdType="pubmed">19671925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>